Exelixis Inc. buy Brookline Capital Management
Start price
23.12.24
/
50%
€31.85
Target price
23.12.25
-
Performance (%)
24.87%
End price
24.12.25
€39.77
Summary
This prediction ended on 24.12.25 with a price of €39.77. The prediction had a final performance of 24.87%. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 1.033% | 1.033% | 19.855% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Brookline_Capital_Ma for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) is now covered by analysts at Brookline Capital Management. They set a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten